Dr. John Moroney, MD
Claim this profileUniversity of Chicago
Area of expertise
Ovarian Cancer
John Moroney, MD has run 10 trials for Ovarian Cancer. Some of their research focus areas include:
Fallopian Tube Cancer
John Moroney, MD has run 6 trials for Fallopian Tube Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of Chicago
University Of Chicago Comprehensive Cancer Center
Clinical Trials John Moroney, MD is currently running
NDI-219216
for Cancer
The goal of this clinical trial is to learn if NDI-219216 is safe for patients, and if NDI-219216 might be a possible treatment for advanced solid tumors in the later phases of the study. The main questions it aims to answer are: Is NDI-219216 safe and what kinds of side effects might it cause? What kind of effects does NDI-219216 have on the body? Does NDI-219216 have any impact on tumor size? Participants will: Take NDI-219216 every day by mouth. Visit the clinic 6 times during Cycle 1, 2 times during Cycle 2, once a month thereafter for checkups and tests while on the study, then one time for an end of treatment visit. After the End of Study, a follow up will occur but can be done on the phone. Keep a diary of their tablet consumption and symptoms experienced.
Recruiting
1 award
Phase 1 & 2
2 criteria
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting
1 award
Phase 2
10 criteria
More about John Moroney, MD
Clinical Trial Related
1 year of experience running clinical trials · Led 17 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments John Moroney, MD has experience with
- Bevacizumab
- Paclitaxel
- Letrozole
- Abemaciclib
- Durvalumab
- Atezolizumab
Breakdown of trials John Moroney, MD has run
Ovarian Cancer
Fallopian Tube Cancer
Endometrial Cancer
Endometrial Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John Moroney, MD specialize in?
John Moroney, MD focuses on Ovarian Cancer and Fallopian Tube Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage III.
Is John Moroney, MD currently recruiting for clinical trials?
Yes, John Moroney, MD is currently recruiting for 5 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that John Moroney, MD has studied deeply?
Yes, John Moroney, MD has studied treatments such as Bevacizumab, Paclitaxel, Letrozole.
What is the best way to schedule an appointment with John Moroney, MD?
Apply for one of the trials that John Moroney, MD is conducting.
What is the office address of John Moroney, MD?
The office of John Moroney, MD is located at: University of Chicago, Chicago, Illinois 60637 United States. This is the address for their practice at the University of Chicago.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.